Public health consequences of screening patients for adherence to highly active antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 26, Issue 2, 2001, Pages 118-129

  Tchetgen, Eric ^a   Kaplan, Edward H ^b   Friedland, Gerald H ^c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE SCHOOL OF MANAGEMENT   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adherence; AIDS incidence; Drug resistance; HAART; Mathematical model

Indexed keywords

ANTIRETROVIRUS AGENT;

ACCURACY; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DOCTOR PATIENT RELATION; HUMAN; INCIDENCE; MATHEMATICAL MODEL; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCREENING TEST;

EID: 0035251480     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200102010-00003     Document Type: Article

References (22)

1. HIV-1 protease inhibitors. A review for clinicians
2. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
3. Reduced antiretroviral drug susceptibility among patients with primary HIV infection
4. Drug resistant HIV-1: The virus strikes back
5. HIV- 1 drug resistance in newly infected individuals
6. Public health implications of antiretroviral therapy and HIV drug resistance
7. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
8. Transmission of antiretroviral-drug-resistant HIV-1 variants
9. The effects of protease inhibitors on the spread of HIV and the development of drug-resistant HIV strains
10. A tale of two futures: HIV and antiretroviral therapy in San Francisco
11. Antiretroviral therapy in adults
12. To treat or not to treat?
13. Viral load and heterosexual transmission of human immunodeficiency virus type 1
14. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
15. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
16. Incidence of zidovudine-resistant human immunodeficiency virus isolated from patients before, during, and after therapy
17. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance
18. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy
19. Antiretroviral adherence issues among HIV-positive adolescents and young adults
20. Attaining higher goals in HIV treatment. The central importance of adherence
21. Adherence, compliance, and HAART